FIELD: biotechnology.
SUBSTANCE: invention relates to a method of obtaining a cell population containing cardiomyocytes, including (1) the stage of contact of a receptor-type tyrosine kinase inhibitor (except for EGF receptor inhibitors) with a cell population containing cardiomyocytes or cardiac progenitor cells, and other cells, where the cell population is obtained by culturing pluripotent stem cells in cardiomyocyte differentiation medium, and (2) a cell population culturing step.
EFFECT: obtaining a population of cells suitable for transplantation therapy of heart diseases and screening of therapeutic agents for heart diseases.
7 cl, 21 dwg, 10 tbl, 9 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF INDUCTION OF PLURIPOTENT STEM CELLS DIFFERENTIATION INTO CARDIOMYOCYTES | 2007 |
|
RU2433174C2 |
| CELL COMPOSITIONS DERIVED FROM DEDIFFERENTIATED REPROGRAMMED CELLS | 2014 |
|
RU2675928C2 |
| METHOD FOR INDUCING DEATH OF PLURIPOTENT STEM CELLS AND DIFFERENTIATED CELLS DIFFERENT FROM CARDIOMYOCYTES | 2010 |
|
RU2551778C2 |
| CELL COMPOSITIONS OBTAINED FROM DEDIFFERENTIATED REPROGRAMMED CELLS | 2014 |
|
RU2754089C2 |
| METHOD OF PRODUCING BIOLOGICAL TISSUE-LIKE STRUCTURE | 2020 |
|
RU2815583C2 |
| METHOD OF CONSTRUCTING MASS OF MYOCARDIAL CELLS AND USE OF MASS OF MYOCARDIAL CELLS | 2008 |
|
RU2467066C2 |
| METHOD FOR PLURIPOTENT STEM CELLS DIFFERENTIATION INTO VASCULAR BED CELLS | 2012 |
|
RU2618871C2 |
| METHODS OF DERIVING DIFFERENTIATED CELLS FROM STEM CELLS | 2009 |
|
RU2576003C2 |
| METHOD OF STEM CELLS DIFFERENTIATION INTO MIOCARDIAL CELLS INDUCTION | 2004 |
|
RU2392315C2 |
| IN VITRO DIFFERENTIATION OF PLURIPOTENT STEM CELLS INTO PANCREATIC ENDODERMAL CELLS (PEC) AND ENDOCRINE CELLS | 2014 |
|
RU2734657C2 |
